Skip to main
MYGN
MYGN logo

Myriad Genetics (MYGN)

$0.00

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

Buy Myriad Genetics (MYGN) Stock

About Myriad Genetics (MYGN)

Myriad Genetics, Inc. engages in the discovery, development, and marketing of transformative molecular diagnostic tests. The company was founded by Walter A. Gilbert, Mark H. Skolnick, and Peter D. Meldrum in May 1991 and is headquartered in Salt Lake City, UT.
Market cap$463.65M
Today's volume617
Revenue (TTM)$831.3M
Avg. daily volume2.12M
EBITDA (TTM)-$29.4M
Open$5.15
Price / earnings ratio-4.51x
Today's range$5.03 - $5.2
Debt / equity22.36x
52 week range$3.81 - $29.3
5 year debt / equity14.63x
Beta (LTM)0.95x
Interest coverage-31.29x
Dividend & yield$0.00 (0.00%)
Current ratio1.9x
Ex-dividend date
Next earningsAug 5, 2025
Dividend payable date

Myriad Genetics Stock Rating

What analysts recommend for MYGN stock, on a scale from 1(buy) to 5(sell).
Hold
Strong Buy 20%
Buy 13%
Hold 47%
Sell 20%
Strong Sell 0%

Frequently Asked Questions (FAQ)

As of Jun 15, 2025, the market cap for MYGN stock is $463.66M

The current P/E ratio for MYGN stock is -4.51

The 52-week high for MYGN stock is $29.30. The current MYGN stock price $undefined is 100.00% below its 52-week high

The 52-week low for MYGN stock is $3.81. The current MYGN stock price $undefined has increased 100.00% from its 52-week low

No, the MYGN stock does not pay dividends to its shareholders

The target price for MYGN stock is $24.67 based on the average of what a group of analyst think MYGN stock could be worth at a future date. This is not a prediction by Public.com

How to buy MYGN stock on Public

  1. 1

    Sign up for a brokerage account on Public

    It’s easy to get started. You can sign up for an account directly on our website or by downloading the Public app for iOS or Android.

  2. 2

    Add funds to your Public account

    There are multiple ways to fund your Public account—from linking a bank account to making a deposit with a debit card or wire transfer.

  3. 3

    Choose how much you'd like to invest in MYGN stock

    Navigate to the Explore page. Then, type MYGN into the search bar. When you see MYGN stock appear in the results, tap it to open up the purchase screen.

  4. 4

    Manage your investments in one place

    You can find your newly purchased MYGN stock in your portfolio—alongside the rest of your stocks, ETFs, crypto, treasuries, and alternative assets.

Myriad Genetics Stock Earnings

The value each MYGN share was expected to gain vs. the value that each MYGN share actually gained.

Myriad Genetics (MYGN) reported Q1 2025 earnings per share (EPS) of -$0.03, beating estimates of -$0.05 by 40.00%. In the same quarter last year, Myriad Genetics's earnings per share (EPS) was -$0.01. Myriad Genetics is expected to release next earnings on 08/05/2025, with an earnings per share (EPS) estimate of $0.

Buy Myriad Genetics (MYGN) Stock

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.